7.27
وفقًا لنظرية اللحظة الإحصائية، فإن متوسط زمن الإقامة (MRT) هو مقياس مهم في الحرائك الدوائية. يمكن تعريف متوسط زمن الإقامة بأنه المتوسط المتوقع ل…
وفقا لنظرية العزم الإحصائي ، فإن متوسط وقت الإقامة هو المتوسط المتوقع لتوزيع دالة كثافة الاحتمال. ويمكن أيضا أن ينظر إليها من منظور التصرف المخدرات في الجسم.
بعد إعطاء البلعة الوريدية ، يتم توزيع جزيئات الدواء وتبقى في الجسم لفترات مختلفة.
يصف متوسط وقت الإقامة متوسط الوقت الذي تبقى فيه جزيئات الدواء في الجسم.
يمكن حسابه من المنطقة الواقعة أسفل منحنى اللحظة مقابل الوقت ، AUMC ، والمنطقة الواقعة تحت منحنى التركيز مقابل الوقت ، AUC ، من الصفر إلى ما لا نهاية.
يمكن استقراء AUMC إلى ما لا نهاية من نقطة معينة ، بافتراض طور طرفي خطي لوغاريتمياني .
ومع ذلك ، لا يمكن حساب AUMC إلا بعد إعطاء جرعة واحدة وليس في ظروف الحالة المستقرة.
نتيجة لذلك ، يمكن حساب متوسط وقت الإقامة بسهولة بعد جرعة دواء واحدة باستخدام النهج غير المجزأ
View the full transcript and gain access to JoVE Core videos
Q1: What is mean residence time in pharmacokinetics?
Mean residence time (MRT) is the expected mean of a probability density function distribution that describes the average time drug molecules stay in the body after administration. According to statistical moment theory, MRT provides valuable insights into drug disposition by quantifying how long a drug remains present in the system following an intravenous bolus injection.
Q2: How is mean residence time calculated from pharmacokinetic data?
Mean residence time is calculated using the ratio of the area under the moment-versus-time curve (AUMC) to the area under the concentration-versus-time curve (AUC), both integrated from zero to infinity. Since infinite measurement is impossible, a log-linear terminal phase assumption extrapolates AUMC to infinity from a given point, enabling accurate MRT computation.
Q3: Why can mean residence time only be calculated after single-dose administration?
Mean residence time calculation is limited to single-dose administration because the mathematical relationship between AUMC and AUC reflects the average residence time for one drug dose. At steady-state conditions with repeated dosing, this relationship breaks down, making MRT values unreliable for continuous or repeated dosing schedules.
Q4: What does the area under the moment-versus-time curve represent?
The area under the moment-versus-time curve (AUMC) provides information about the distribution and residence of drug molecules in the body over time. When combined with the area under the concentration-versus-time curve, AUMC enables calculation of mean residence time through the noncompartmental approach.
Q5: How does mean residence time relate to drug disposition in the body?
After intravenous bolus administration, drug molecules distribute throughout the body and reside there for varying periods. Mean residence time quantifies this disposition by representing the average duration these molecules remain in the system, offering clinicians insight into how quickly a drug is eliminated and how long therapeutic effects persist.
Q6: What is the noncompartmental approach in mean residence time analysis?
The noncompartmental approach is a model-independent methodology that calculates mean residence time using available data from single-dose administration without assuming specific compartment structures. This approach employs equations and algorithms to estimate MRT accurately by analyzing the relationship between AUMC and AUC values.
Q7: Why is the log-linear terminal phase assumption necessary for mean residence time calculation?
The log-linear terminal phase assumption allows extrapolation of the area under the moment-versus-time curve to infinity from a measured point, since it is impossible to obtain drug concentration measurements infinitely. This assumption enables practical calculation of mean residence time by providing a mathematical framework to estimate the tail of the AUMC curve.